BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22820033)

  • 1. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design.
    Hao J; Wang F; Wang X; Zhang D; Bi Y; Gao Y; Zhao X; Zhang Q
    Eur J Pharm Sci; 2012 Sep; 47(2):497-505. PubMed ID: 22820033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
    Lingling G; Yuan Z; Weigen L
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of baicalin nanocrystal pellets and preliminary study on its pharmacokinetics].
    Jin SY; Yuan HL; Jin SX; Lv QY; Bai JX; Han J
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1156-9. PubMed ID: 23944028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
    Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
    Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
    Negi JS; Chattopadhyay P; Sharma AK; Ram V
    Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
    Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
    Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.